...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Resverlogix Announces Publication in High-impact Peer-reviewed Journal – Medicinal Research Reviews

Really like the tone of that news release!

The authors conclude that the research into selective BET inhibitors shows significant promise, writing: “Focused development of BD‐selective compounds is certain to alter and expand the clinical landscape for years to come.”

GET IT DONE DON!!!

Share
New Message
Please login to post a reply